Trials / Completed
CompletedNCT02407249
Topera C-FIRM Registry
Control for EU (European Union) Focal Impulse and Rotor Modulation Registry - Topera C-FIRM Registry-
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 73 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a control registry to the E-FIRM registry to track conventional atrial fibrillation (AF) procedures in terms of clinical usage, handling, and the safety and effectiveness for the treatment of symptomatic atrial fibrillation. Conventional AF ablation is defined as pulmonary vein isolation (PVI) and any additional ablation for AF according to the standard routine of the center. Data items will be collected, if available, consistent and applicable with routine and standard clinical care at each participating site.
Detailed description
Prospective and retrospective enrollment possible
Conditions
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2017-05-31
- Completion
- 2018-07-31
- First posted
- 2015-04-02
- Last updated
- 2019-10-16
- Results posted
- 2019-10-16
Locations
9 sites across 2 countries: Germany, Netherlands
Source: ClinicalTrials.gov record NCT02407249. Inclusion in this directory is not an endorsement.